amgen said started preparing $ 50million offering subordinated convertible debentures investors overseas mainly europe a convertible debenture unsecured bond ultimately may exchanged stock company amgen thousand oaks biotechnology company assisted preparing offering morgan stanley international earlier month us food drug administration approved sale amgens biotechnology drug erythropoietin longawaited protein treats chronic anemia patients kidney disease